These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
399 related items for PubMed ID: 22002933
1. Optimization of a glycoengineered Pichia pastoris cultivation process for commercial antibody production. Ye J, Ly J, Watts K, Hsu A, Walker A, McLaughlin K, Berdichevsky M, Prinz B, Sean Kersey D, d'Anjou M, Pollard D, Potgieter T. Biotechnol Prog; 2011; 27(6):1744-50. PubMed ID: 22002933 [Abstract] [Full Text] [Related]
2. Production of monoclonal antibodies by glycoengineered Pichia pastoris. Potgieter TI, Cukan M, Drummond JE, Houston-Cummings NR, Jiang Y, Li F, Lynaugh H, Mallem M, McKelvey TW, Mitchell T, Nylen A, Rittenhour A, Stadheim TA, Zha D, d'Anjou M. J Biotechnol; 2009 Feb 23; 139(4):318-25. PubMed ID: 19162096 [Abstract] [Full Text] [Related]
3. Methanol induction optimization for scFv antibody fragment production in Pichia pastoris. Cunha AE, Clemente JJ, Gomes R, Pinto F, Thomaz M, Miranda S, Pinto R, Moosmayer D, Donner P, Carrondo MJ. Biotechnol Bioeng; 2004 May 20; 86(4):458-67. PubMed ID: 15112298 [Abstract] [Full Text] [Related]
4. Improved production of monoclonal antibodies through oxygen-limited cultivation of glycoengineered yeast. Berdichevsky M, d'Anjou M, Mallem MR, Shaikh SS, Potgieter TI. J Biotechnol; 2011 Sep 10; 155(2):217-24. PubMed ID: 21723345 [Abstract] [Full Text] [Related]
6. Human chymotrypsinogen B production with Pichia pastoris by integrated development of fermentation and downstream processing. Part 1. Fermentation. Curvers S, Brixius P, Klauser T, Thömmes J, Weuster-Botz D, Takors R, Wandrey C. Biotechnol Prog; 2001 Aug 15; 17(3):495-502. PubMed ID: 11386871 [Abstract] [Full Text] [Related]
7. [The effect of fermentation conditions on glycosylation of recombinant human interferon omega in yeast Pichia pastoris]. Liu H, Pan HC, Cai SX, Chen ZW, Zheng XF, Yang HT, Xiao ZY. Sheng Wu Gong Cheng Xue Bao; 2005 Jan 15; 21(1):107-12. PubMed ID: 15859338 [Abstract] [Full Text] [Related]
8. Optimization of humanized IgGs in glycoengineered Pichia pastoris. Li H, Sethuraman N, Stadheim TA, Zha D, Prinz B, Ballew N, Bobrowicz P, Choi BK, Cook WJ, Cukan M, Houston-Cummings NR, Davidson R, Gong B, Hamilton SR, Hoopes JP, Jiang Y, Kim N, Mansfield R, Nett JH, Rios S, Strawbridge R, Wildt S, Gerngross TU. Nat Biotechnol; 2006 Feb 15; 24(2):210-5. PubMed ID: 16429149 [Abstract] [Full Text] [Related]
9. A high-throughput purification of monoclonal antibodies from glycoengineered Pichia pastoris. Jiang Y, Li F, Button M, Cukan M, Moore R, Sharkey N, Li H. Protein Expr Purif; 2010 Nov 15; 74(1):9-15. PubMed ID: 20447459 [Abstract] [Full Text] [Related]
10. An optimized fermentation process for high-level production of a single-chain Fv antibody fragment in Pichia pastoris. Damasceno LM, Pla I, Chang HJ, Cohen L, Ritter G, Old LJ, Batt CA. Protein Expr Purif; 2004 Sep 15; 37(1):18-26. PubMed ID: 15294276 [Abstract] [Full Text] [Related]
11. An ultra scale-down approach to assess the impact of the choice of recombinant P. pastoris strain on dewatering performance in centrifuges. Lopes AG, Khan N, Liddell J, Keshavarz-Moore E. Biotechnol Prog; 2012 Jul 15; 28(4):1029-36. PubMed ID: 22641601 [Abstract] [Full Text] [Related]
13. Influence of specific growth rate on specific productivity and glycosylation of a recombinant avidin produced by a Pichia pastoris Mut+ strain. Schenk J, Balazs K, Jungo C, Urfer J, Wegmann C, Zocchi A, Marison IW, von Stockar U. Biotechnol Bioeng; 2008 Feb 01; 99(2):368-77. PubMed ID: 17636485 [Abstract] [Full Text] [Related]
14. Oxygen-limited control of methanol uptake for improved production of a single-chain antibody fragment with recombinant Pichia pastoris. Khatri NK, Hoffmann F. Appl Microbiol Biotechnol; 2006 Sep 01; 72(3):492-8. PubMed ID: 16532314 [Abstract] [Full Text] [Related]
15. Genome-scale metabolic model of Pichia pastoris with native and humanized glycosylation of recombinant proteins. Irani ZA, Kerkhoven EJ, Shojaosadati SA, Nielsen J. Biotechnol Bioeng; 2016 May 01; 113(5):961-9. PubMed ID: 26480251 [Abstract] [Full Text] [Related]
16. Analysis of single-chain antibody production in Pichia pastoris using on-line methanol control in fed-batch and mixed-feed fermentations. Hellwig S, Emde F, Raven NP, Henke M, van Der Logt P, Fischer R. Biotechnol Bioeng; 2001 Aug 20; 74(4):344-52. PubMed ID: 11410859 [Abstract] [Full Text] [Related]
17. Purification process development of a recombinant monoclonal antibody expressed in glycoengineered Pichia pastoris. Jiang Y, Li F, Zha D, Potgieter TI, Mitchell T, Moore R, Cukan M, Houston-Cummings NR, Nylen A, Drummond JE, McKelvey TW, d'Anjou M, Stadheim TA, Sethuraman N, Li H. Protein Expr Purif; 2011 Mar 20; 76(1):7-14. PubMed ID: 21074617 [Abstract] [Full Text] [Related]
18. Functional recombinant protein is present in the pre-induction phases of Pichia pastoris cultures when grown in bioreactors, but not shake-flasks. Bawa Z, Routledge SJ, Jamshad M, Clare M, Sarkar D, Dickerson I, Ganzlin M, Poyner DR, Bill RM. Microb Cell Fact; 2014 Sep 04; 13(1):127. PubMed ID: 25186468 [Abstract] [Full Text] [Related]
19. Process technology for production and recovery of heterologous proteins with Pichia pastoris. Jahic M, Veide A, Charoenrat T, Teeri T, Enfors SO. Biotechnol Prog; 2006 Sep 04; 22(6):1465-73. PubMed ID: 17137292 [Abstract] [Full Text] [Related]
20. Developing high cell density fed-batch cultivation strategies for heterologous protein production in Pichia pastoris using the nitrogen source-regulated FLD1 Promoter. Resina D, Cos O, Ferrer P, Valero F. Biotechnol Bioeng; 2005 Sep 20; 91(6):760-7. PubMed ID: 15918169 [Abstract] [Full Text] [Related] Page: [Next] [New Search]